Literature DB >> 6808028

Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture.

T A Luger, J S Smolen, T M Chused, A D Steinberg, J J Oppenheim.   

Abstract

In this study, we demonstrate that both highly purified T4+ and T8+ lymphocytes can produce substantial amounts of Interleukin 2(IL 2) when stimulated with the combination of concanavalin A (Con A) and phorbol myristate acetate. Furthermore, addition of IL 1 to macrophage-depleted T lymphocytes significantly increased IL 2 production by lymphocytes of either the T4+ or T8+ phenotype. These findings provide a basis for further studies of the molecular mechanisms involved in human immune cell interactions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6808028      PMCID: PMC371256          DOI: 10.1172/jci110637

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate.

Authors:  D L Rosenstreich; S B Mizel
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  Relationship between IL 2 synthesis and the proliferative response to PHA in different primary immunodeficiencies.

Authors:  M López-Botet; G Fontán; M C Garcia Rodriguez; M O de Landázuri
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

4.  Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.

Authors:  B M Stadler; S F Dougherty; J J Farrar; J J Oppenheim
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

5.  Macrophage-independent activation of helper T cells. I. Production of Interleukin 2.

Authors:  J J Farrar; S B Mizel; J Fuller-Farrar; W L Farrar; M L Hilfiker
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

6.  Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells.

Authors:  K A Smith; K J Gilbride; M F Favata
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

7.  Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations.

Authors:  E L Reinherz; C Morimoto; K A Fitzgerald; R E Hussey; J F Daley; S F Schlossman
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  The human autologous mixed lymphocyte reaction. I. Suppression by macrophages and T cells.

Authors:  J S Smolen; S O Sharrow; J P Reeves; W A Boegel; A D Steinberg
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

9.  Responder cells in the human autologous mixed lymphocyte reaction.

Authors:  J S Smolen; T A Luger; T M Chused; A D Steinberg
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

10.  T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved.

Authors:  E L Reinherz; P C Kung; J M Breard; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

View more
  26 in total

1.  Interleukin-2 production of lymphocytes in food sensitive atopic dermatitis.

Authors:  H Agata; N Kondo; O Fukutomi; S Shinoda; T Orii
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

Review 2.  Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia.

Authors:  B T Shannon; J Roach; M Cheek-Luten; C Orosz; F B Ruymann
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

Review 3.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

4.  OKT4+ and OKT8+ T lymphocytes produce soluble factors that can modulate growth and differentiation of human B cells.

Authors:  T Sakane; Y Ueda; N Suzuki; Y Niwa; T Hoshino; T Tsunematsu
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

5.  Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.

Authors:  J S Smolen; P Bettelheim; U Köller; S McDougal; W Graninger; T A Luger; W Knapp; K Lechner
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

6.  Decreased interleukin 2 inhibitor in sera of patients with autoimmune disorders.

Authors:  J Y Djeu; T Kasahara; J E Balow; G C Tsokos
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

7.  T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome.

Authors:  R Topaloğlu; U Saatçi; M Arikan; H Canpinar; A Bakkaloğlu; E Kansu
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

8.  Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study.

Authors:  K Morris; C Mohan; P L Wahi; I S Anand; N K Ganguly
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

9.  Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.

Authors:  K Yoshioka; S Kakumu; H Murakami; K Fukui
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

10.  Influence of activating stimulus on functional phenotype: interleukin 2 mRNA accumulation differentially induced by ionophore and receptor ligands in subsets of murine T cells.

Authors:  K L McGuire; J A Yang; E V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.